9-133422087-T-C
Position:
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The ENST00000371929(ADAMTS13):c.-357T>C variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0723 in 294,420 control chromosomes in the GnomAD database, including 914 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.076 ( 500 hom., cov: 32)
Exomes 𝑓: 0.068 ( 414 hom. )
Consequence
ADAMTS13
ENST00000371929 5_prime_UTR
ENST00000371929 5_prime_UTR
Scores
2
Clinical Significance
Conservation
PhyloP100: -1.68
Genes affected
ADAMTS13 (HGNC:1366): (ADAM metallopeptidase with thrombospondin type 1 motif 13) This gene encodes a member of a family of proteins containing several distinct regions, including a metalloproteinase domain, a disintegrin-like domain, and a thrombospondin type 1 (TS) motif. The enzyme encoded by this gene specifically cleaves von Willebrand Factor (vWF). Defects in this gene are associated with thrombotic thrombocytopenic purpura. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jul 2013]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.97).
BP6
Variant 9-133422087-T-C is Benign according to our data. Variant chr9-133422087-T-C is described in ClinVar as [Likely_benign]. Clinvar id is 365531.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.0859 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ADAMTS13 | XM_017014232.2 | c.93+109T>C | intron_variant | XP_016869721.1 | ||||
ADAMTS13 | XM_017014233.2 | c.-285-1014T>C | intron_variant | XP_016869722.1 | ||||
ADAMTS13 | NR_024514.3 | n.309-1014T>C | intron_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ADAMTS13 | ENST00000371929 | c.-357T>C | 5_prime_UTR_variant | 1/29 | 1 | ENSP00000360997.3 | ||||
ADAMTS13 | ENST00000485925.5 | n.288-1014T>C | intron_variant | 1 | ||||||
ADAMTS13 | ENST00000371916 | c.-1101T>C | 5_prime_UTR_variant | 1/26 | 5 | ENSP00000360984.2 |
Frequencies
GnomAD3 genomes AF: 0.0759 AC: 11544AN: 152052Hom.: 500 Cov.: 32
GnomAD3 genomes
AF:
AC:
11544
AN:
152052
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.0684 AC: 9724AN: 142252Hom.: 414 Cov.: 0 AF XY: 0.0641 AC XY: 4671AN XY: 72870
GnomAD4 exome
AF:
AC:
9724
AN:
142252
Hom.:
Cov.:
0
AF XY:
AC XY:
4671
AN XY:
72870
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0759 AC: 11556AN: 152168Hom.: 500 Cov.: 32 AF XY: 0.0740 AC XY: 5508AN XY: 74400
GnomAD4 genome
AF:
AC:
11556
AN:
152168
Hom.:
Cov.:
32
AF XY:
AC XY:
5508
AN XY:
74400
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
68
AN:
3478
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Likely benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | Jun 18, 2021 | - - |
Upshaw-Schulman syndrome Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jun 14, 2016 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at